Stent revascularization for the prevention of cardiovascular and renal events among patients with renal artery stenosis and systolic hypertension: rationale and design of the CORAL trial.
about
Balloon angioplasty, with and without stenting, versus medical therapy for hypertensive patients with renal artery stenosisBalloon angioplasty versus medical therapy for hypertensive patients with renal artery obstructionRenal artery stenosis-when to screen, what to stent?Update on intervention versus medical therapy for atherosclerotic renal artery stenosis2011 ACCF/AHA Focused Update of the Guideline for the Management of Patients With Peripheral Artery Disease (updating the 2005 guideline): a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice GuRenal Artery Stent Outcomes: Effect of Baseline Blood Pressure, Stenosis Severity, and Translesion Pressure GradientRoll-in experience from the Cardiovascular Outcomes with Renal Atherosclerotic Lesions (CORAL) study.Stenting and medical therapy for atherosclerotic renal-artery stenosisIs fibromuscular dysplasia underdiagnosed? A comparison of the prevalence of FMD seen in CORAL trial participants versus a single institution population of renal donor candidates.Atherosclerotic renovascular disease among hypertensive adultsUse of renin-angiotensin inhibitors in people with renal artery stenosisCardio classics revisited--focus on the role of candesartan.Atherosclerotic renal artery stenosis is prevalent in cardiorenal patients but not associated with left ventricular function and myocardial fibrosis as assessed by cardiac magnetic resonance imaging.Renal ostial angioplasty and stenting. Part 1: the routine procedure.Common secondary causes of resistant hypertension and rational for treatmentRenovascular hypertension and ischemic nephropathy.Consequences of frequent hemodialysis: comparison to conventional hemodialysis and transplantation.Hypertension in chronic kidney disease: navigating the evidence.Atherosclerotic renal artery stenosis--diagnosis and treatment.Renovascular hypertension: screening and modern management.Regional and physician specialty-associated variations in the medical management of atherosclerotic renal-artery stenosis.Clinical outcomes in patients with renal artery stenosis treated with stent placement with embolic protection compared with those treated with stent alone2011 ACCF/AHA focused update of the guideline for the management of patients with peripheral artery disease (updating the 2005 guideline): a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice GuPlatelet activation in patients with atherosclerotic renal artery stenosis undergoing stent revascularizationRX Herculink Elite(®) renal stent system: a review of its use for the treatment of renal artery stenosis.Renal artery stenosis: optimizing diagnosis and treatment.Renal artery stenosis and cardiovascular risk.Mesenchymal stem cells improve medullary inflammation and fibrosis after revascularization of swine atherosclerotic renal artery stenosis.Characterization of blaKPC-containing Klebsiella pneumoniae isolates detected in different institutions in the Eastern USA.The role of percutaneous revascularization for renal artery stenosis.Experience of stenting for atherosclerotic renal artery stenosis in a cardiac catheterization laboratory: technical considerations and complications.Revascularization as a treatment to improve renal function.Current options for the treatment of resistant hypertension.Cardiovascular morbidity and mortality and renal artery stenosis.ACCF/AHA/ACR/SCAI/SIR/SVM/SVN/SVS 2010 performance measures for adults with peripheral artery disease. A Report of the American College of Cardiology Foundation/American Heart Association Task Force on Performance Measures, the American College of RContemporary management of atherosclerotic renovascular disease: before and after ASTRAL.The management of atherosclerotic renovascular disease.Atherosclerotic renal artery stenosis and renal artery stenting: an evolving therapeutic option.Management of hypertension in the elderly.Off-label use of drugs and medical devices: a review of policy implications.
P2860
Q24187429-8C5B85AB-65A3-497D-AEF9-16C13ECB05E8Q24248023-0DA7B4B8-3517-495F-9C91-2D6D715B65B0Q26829330-ABE0A15C-FD76-4ECE-ACC2-370FA2492F8DQ27026297-13362D28-71D4-4F6A-8604-F1EE28638CD3Q28249469-B0705ECB-042E-43E5-A70A-1893DB9EF79BQ30277927-3E2DD062-0F94-4BDE-90EE-90567CB30565Q30360047-CCB2D611-308F-4B87-80F9-8998E18B534AQ30360052-72D76E29-1226-4E06-9A4E-67524F92208DQ30458782-22F1CCF6-F64E-416E-872B-3A5F36495AB3Q30480594-6487278B-FA6E-43ED-9D43-DE795955D55FQ33835760-BED5FB0E-E95E-4416-80AB-3B6C9A04BD68Q34417462-599023B8-28F5-44B0-9340-07922B8E7043Q34417974-1BFC0D4B-DF56-47D4-8029-9A696C007439Q34563694-817BE3FB-F398-40C7-974B-7A42E1AEEED5Q34669789-5154BF23-7E78-4EDF-893B-67FB12800986Q34807128-89F7B87C-ADE1-42F9-9A9D-91C37110FB7CQ35048989-66D54178-DBCF-4ED3-B3BC-8C6B01680679Q35071147-7AE4AC2C-DFAB-4406-840F-ACEDC2F4B9B3Q35080587-A198F91C-F0A4-4BC7-8495-0A0F75907406Q35082711-F9FFA47F-B473-4A92-B938-38E4E625C2A6Q35699863-7A14BCBD-6559-4398-B062-049FA1C3DDF4Q35800116-41E15E5C-A019-40CE-ADAB-984A242893E5Q35860891-C3B8EFCD-A905-408B-A6EE-79DCF26DADEAQ35983451-5C0741F8-644F-47EB-B77A-3086A96D7D7FQ36395642-A9A84ED0-24DD-4359-A6E5-DDBA79BCB3E7Q36711107-8B3F570E-6776-4AB0-93F6-0CFB27D81243Q36753245-063169A7-C799-4909-A9C9-A634BAE2CB62Q36981313-36E932CA-FE4D-4B68-9A52-93EA7F2AA443Q37092395-E76CBF9A-F8CF-4BCC-A5FA-033127E26577Q37204525-AFAB1850-AA74-4983-BA90-27B43B50C9D9Q37319868-A2EFF95E-2C31-4E47-A43E-C6FEFBF02F98Q37601238-FC044CB4-C8CE-4F3B-9865-A4D33E6B58A5Q37629838-D8CC5FD3-A3B5-4257-BE95-594626E775DBQ37633683-45CDE7FB-FF5D-413C-8A51-D07B33662C25Q37823798-68A7CD50-8C5A-45A2-B1DE-EE66A332570CQ37873966-46D37B90-5CFC-479D-A866-41BE068C3211Q37892315-C045E5D3-DF18-4EF8-A2AD-895D38E1FB77Q37943868-848068D8-8537-4380-8659-BE1529C930B3Q37992922-50310FBE-C73F-43E0-94E7-7F79D6340B93Q37999651-D6653800-BB77-435E-9B8C-966653AE26F3
P2860
Stent revascularization for the prevention of cardiovascular and renal events among patients with renal artery stenosis and systolic hypertension: rationale and design of the CORAL trial.
description
2006 nî lūn-bûn
@nan
2006年の論文
@ja
2006年学术文章
@wuu
2006年学术文章
@zh
2006年学术文章
@zh-cn
2006年学术文章
@zh-hans
2006年学术文章
@zh-my
2006年学术文章
@zh-sg
2006年學術文章
@yue
2006年學術文章
@zh-hant
name
Stent revascularization for th ...... and design of the CORAL trial.
@en
Stent revascularization for th ...... and design of the CORAL trial.
@nl
type
label
Stent revascularization for th ...... and design of the CORAL trial.
@en
Stent revascularization for th ...... and design of the CORAL trial.
@nl
prefLabel
Stent revascularization for th ...... and design of the CORAL trial.
@en
Stent revascularization for th ...... and design of the CORAL trial.
@nl
P2093
P921
P1476
Stent revascularization for th ...... and design of the CORAL trial.
@en
P2093
Alan Matsumoto
Christopher J Cooper
David J Cohen
Diane Reid
John Rundback
Kenneth Jamerson
Kenneth Rosenfield
Lance Dworkin
Michael Jaff
Michael Steffes
P356
10.1016/J.AHJ.2005.09.011
P407
P577
2006-07-01T00:00:00Z